Real World Data on Gi(l)Otrif® Dose Adjustment

CompletedOBSERVATIONAL
Enrollment

228

Participants

Timeline

Start Date

November 24, 2016

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Carcinoma, Non-Small-Cell Lung
Trial Locations (29)

1140

SMZ Baumgartner Hoehe Otto Wagner Spital, Vienna

10461

Montefiore Medical Center, The Bronx

15121

Azienda Ospedaliera Santi Antonio e Biagio e Cesare Arrigo, Alessandria

21079

HOP Dijon, Cardio-Pneumo, Dijon, Dijon

25030

HOP Jean Minjoz, Besançon

26121

Pius-Hospital, Oldenburg, Oldenburg

28006

Hospital La Princesa, Madrid

28201

Levine Cancer Institute, Charlotte

31331

Grzegorz Czyzewicz Specialised Medical Practice, Cracow, Krakow

40447

China Medical University Hospital, Taichung

45050

Unidad de Cancerologia, Zapopan

45147

Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH, Essen

49241

Pusan National Univ. Hosp, Pusan

54907

Chonbuk National University Hospital, Jeonju

64060

Organización para Cuidado Integral en Oncología S.A de C.V, Monterrey

73100

Azienda Ospedaliera Vito Fazzi, Lecce

75908

HOP Européen G. Pompidou, Paris

75970

HOP Tenon, Paris

85796

Medical Practice,Bogdan Zurawski,Private Practice,Bydgoszcz, Bydgoszcz

90419

Klinikum Nürnberg, Nuremberg

119228

National University Hospital, Singapore

169610

National Cancer Centre, Singapore

V5Z 4E6

BC Cancer Agency - Vancouver, Vancouver

464-8681

Aichi Cancer Center Hospital, Aichi, Nagoya

710-8602

Kurashiki Central Hospital, Okayama, Kurashiki

01120

Centro Medico ABC, Mexico City

60-569

Greater PL Cent.Pulmo.&Thor.Surg.Eugenia&Janusz Zeyland, Poznan

705-703

Yeungnam University Medical Center, Daegu

08916

Hospital Germans Trias i Pujol, Badalona (Barcelona)

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY